A phase II study of neoadjuvant chemotherapy with bevacizumab plus mFOLFOX6 for resectable synchronous liver metastasis (SLM) from colorectal cancer: The first report of the Miyagi Hepato-Biliary Pancreatic Clinical Oncology Group.
Yu Katayose
No relevant relationships to disclose
Junichiro Yamauchi
No relevant relationships to disclose
Masaya Oikawa
No relevant relationships to disclose
Naoki Sakurai
No relevant relationships to disclose
Hiroaki Musya
No relevant relationships to disclose
Hiromune Shimamura
No relevant relationships to disclose
Koh Miura
No relevant relationships to disclose
Kei Nakagawa
No relevant relationships to disclose
Shinichi Egawa
No relevant relationships to disclose
Michiaki Unno
No relevant relationships to disclose